SELLAS Life Sciences Group, Inc. (SLS)
10.60
+0.62
(+6.21%)
USD |
NASDAQ |
Oct 19, 14:00
SELLAS Life Sciences Group Cash from Operations (Annual) : -28.39M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -28.39M |
| December 31, 2024 | -35.40M |
| December 31, 2023 | -31.41M |
| December 31, 2022 | -23.81M |
| December 31, 2021 | -26.02M |
| December 31, 2020 | -10.42M |
| December 31, 2019 | -17.64M |
| December 31, 2018 | -30.42M |
| December 31, 2017 | -10.99M |
| December 31, 2016 | -11.85M |
| December 31, 2015 | -48.16M |
| Date | Value |
|---|---|
| December 31, 2014 | -42.87M |
| December 31, 2013 | -28.91M |
| December 31, 2012 | -20.96M |
| December 31, 2011 | -14.67M |
| December 31, 2010 | -10.26M |
| December 31, 2009 | -11.77M |
| December 31, 2008 | -9.429M |
| December 31, 2007 | -6.047M |
| December 31, 2006 | -2.112M |
| December 31, 2005 | -2.526M |
| December 31, 2004 | -1.28M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| AbbVie, Inc. | 19.03B |
| ImmunityBio, Inc. | -304.94M |
| TG Therapeutics, Inc. | -24.77M |
| Capricor Therapeutics, Inc. | -69.81M |
| Relay Therapeutics, Inc. | -235.46M |